Delivery Order SPE2DB20D1109-SPE2DB25FN94A
Award Date
4/22/25
Potential Completion Date
4/23/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a medical product, with a ceiling value of $1,464.99 and a completion date of May 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a firm-fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $2,326.45, is for the supply of the pharmaceutical product OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML. The contract has an ultimate completion date of June 9, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order has a ceiling value of $2,473.13 and a period of performance through March 18, 2024. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,330.33, is for the delivery of OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a medical product, with a completion date of April 1, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The award has a ceiling value of $1,149.49 and is a firm fixed price contract. The place of performance is Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a for-profit organization...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a specialty pharmaceutical product, with a ceiling value of $2,599.92 and a period of performance through March 25, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract has a ceiling value of $1,382.31 and runs through September 9, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,687.94 firm fixed-price delivery order is for the pharmaceutical product OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML. The contract has an ultimate completion date of March 20, 2025 and was awarded on March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,128.95 firm-fixed-price contract is for the medical product "OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML". The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026....
This is a federal delivery order award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $11,578.02 firm-fixed-price contract is for the supply of OTEZLA 30 MG TABLET 60S medication. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...